Alphyn Expands Patent Estate with New U.S. Patent for Atopic Dermatitis Therapeutic
By SquaredTown on October 27, 2025
Patent covers active pharmaceutical ingredient with protection until 2041 ANNAPOLIS, Md., Oct. 27, 2025 /PRNewswire/ -- Alphyn, a clinical-stage dermatology company developing first-in-class Multi-Target Therapeutics®, announced today that the U.S. Patent and Trademark Office (USPTO) has...